{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:56:39Z","timestamp":1781326599855,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"DOI":"10.1038\/s41418-026-01778-7","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:16:12Z","timestamp":1781324172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM17 downregulation modulates CRPC progression and enzalutamide resistance by derepressing BCL2 expression via the p53-dependent and p53-independent pathways"],"prefix":"10.1038","author":[{"given":"Zhi","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyuan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5942-4893","authenticated-orcid":false,"given":"Zhe","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6761-5195","authenticated-orcid":false,"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"1778_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1778_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"1778_CR3","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1200\/JCO.23.00433","volume":"41","author":"C Dai","year":"2023","unstructured":"Dai C, Dehm SM, Sharifi N. Targeting the androgen signaling axis in prostate cancer. J Clin Oncol. 2023;41:4267\u201378.","journal-title":"J Clin Oncol"},{"key":"1778_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai K, McManus JM, Sharifi N. Hormonal therapy for prostate cancer. Endocr Rev. 2021;42:354\u201373.","journal-title":"Endocr Rev"},{"key":"1778_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song XL, Li XA, Chen M, Guo J, Yang DH, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updat. 2023;68:100962.","journal-title":"Drug Resist Updat"},{"key":"1778_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrd.2016.120","volume":"15","author":"TA Yap","year":"2016","unstructured":"Yap TA, Smith AD, Ferraldeschi R, Al-Lazikani B, Workman P, de Bono JS. Drug discovery in advanced prostate cancer: translating biology into therapy. Nat Rev Drug Discov. 2016;15:699\u2013718.","journal-title":"Nat Rev Drug Discov"},{"key":"1778_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nrc3139","volume":"11","author":"S Hatakeyama","year":"2011","unstructured":"Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer. 2011;11:792\u2013804.","journal-title":"Nat Rev Cancer"},{"key":"1778_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tibs.2017.01.002","volume":"42","author":"S Hatakeyama","year":"2017","unstructured":"Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42:297\u2013311.","journal-title":"Trends Biochem Sci"},{"key":"1778_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jb\/mvr128","volume":"151","author":"H Endo","year":"2012","unstructured":"Endo H, Ikeda K, Urano T, Horie-Inoue K, Inoue S. Terf\/TRIM17 stimulates degradation of kinetochore protein ZWINT and regulates cell proliferation. J Biochem. 2012;151:139\u201344.","journal-title":"J Biochem"},{"key":"1778_CR10","first-page":"1535","volume":"14","author":"S Xiao","year":"2022","unstructured":"Xiao S, Yu J, Yuan X, Chen Q. Identification of a tripartite motif family gene signature for predicting the prognosis of patients with glioma. Am J Transl Res. 2022;14:1535\u201350.","journal-title":"Am J Transl Res"},{"key":"1778_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08070-5","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Zheng D, Huang X, Wei Z, Wei Z, Guo W. TRIM17 promotes the progression of osteosarcoma by regulating PDK1 m6A modification-mediated AKT\/mTOR pathway activation through ubiquitination of FTO. Cell Death Dis. 2025;16:767.","journal-title":"Cell Death Dis"},{"key":"1778_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41418-018-0169-5","volume":"26","author":"L Lionnard","year":"2019","unstructured":"Lionnard L, Duc P, Brennan MS, Kueh AJ, Pal M, Guardia F, et al. TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1. Cell Death Differ. 2019;26:902\u201317.","journal-title":"Cell Death Differ"},{"key":"1778_CR13","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s13402-023-00825-6","volume":"46","author":"T Zhong","year":"2023","unstructured":"Zhong T, Zhang J, Liu X, Li H. TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer. Cell Oncol. 2023;46:1493\u2013507.","journal-title":"Cell Oncol"},{"key":"1778_CR14","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1038\/s41418-023-01221-1","volume":"30","author":"J Shen","year":"2023","unstructured":"Shen J, Yang H, Qiao X, Chen Y, Zheng L, Lin J, et al. The E3 ubiquitin ligase TRIM17 promotes gastric cancer survival and progression via controlling BAX stability and antagonizing apoptosis. Cell Death Differ. 2023;30:2322\u201335.","journal-title":"Cell Death Differ"},{"key":"1778_CR15","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1038\/s41418-023-01232-y","volume":"30","author":"P Liu","year":"2023","unstructured":"Liu P, Zhao L, Zitvogel L, Kepp O, Kroemer G. The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation. Cell Death Differ. 2023;30:2447\u201351.","journal-title":"Cell Death Differ"},{"key":"1778_CR16","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-23-0308","volume":"83","author":"Z Li","year":"2023","unstructured":"Li Z, Ning K, Zhao D, Zhou Z, Zhao J, Long X, et al. Targeting the metabolic enzyme PGAM2 overcomes enzalutamide resistance in castration-resistant prostate cancer by inhibiting BCL2 signaling. Cancer Res. 2023;83:3753\u201366.","journal-title":"Cancer Res"},{"key":"1778_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40087-2","volume":"14","author":"H Wei","year":"2023","unstructured":"Wei H, Wang H, Wang G, Qu L, Jiang L, Dai S, et al. Structures of p53\/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity. Nat Commun. 2023;14:4300.","journal-title":"Nat Commun"},{"key":"1778_CR18","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/s41418-020-00701-y","volume":"28","author":"JO Jin","year":"2021","unstructured":"Jin JO, Lee GD, Nam SH, Lee TH, Kang DH, Yun JK, et al. Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis. Cell Death Differ. 2021;28:1790\u2013803.","journal-title":"Cell Death Differ"},{"key":"1778_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41852-z","volume":"14","author":"Z Ding","year":"2023","unstructured":"Ding Z, Pan Y, Shang T, Jiang T, Lin Y, Yang C, et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat Commun. 2023;14:6269.","journal-title":"Nat Commun"},{"key":"1778_CR20","doi-asserted-by":"crossref","unstructured":"Basu-Shrivastava M, Kozoriz A, Desagher S, Lassot I. To ubiquitinate or not to ubiquitinate: TRIM17 in cell life and death. Cells. 2021; 10:1235.","DOI":"10.3390\/cells10051235"},{"key":"1778_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/cdd.2012.124","volume":"20","author":"MM Magiera","year":"2013","unstructured":"Magiera MM, Mora S, Mojsa B, Robbins I, Lassot I, Desagher S. Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons. Cell Death Differ. 2013;20:281\u201392.","journal-title":"Cell Death Differ"},{"key":"1778_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01897-z","volume":"22","author":"S Zheng","year":"2024","unstructured":"Zheng S, Hong Z, Tan Y, Wang Y, Li J, Zhang Z, et al. MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway. Cell Commun Signal. 2024;22:517.","journal-title":"Cell Commun Signal"},{"key":"1778_CR23","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/cdd.2010.73","volume":"17","author":"I Lassot","year":"2010","unstructured":"Lassot I, Robbins I, Kristiansen M, Rahmeh R, Jaudon F, Magiera MM, et al. Trim17, a novel E3 ubiquitin-ligase, initiates neuronal apoptosis. Cell Death Differ. 2010;17:1928\u201341.","journal-title":"Cell Death Differ"},{"key":"1778_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27210-x","volume":"12","author":"D Lv","year":"2021","unstructured":"Lv D, Pal P, Liu X, Jia Y, Thummuri D, Zhang P, et al. Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun. 2021;12:6896.","journal-title":"Nat Commun"},{"key":"1778_CR25","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1158\/1078-0432.CCR-20-3260","volume":"27","author":"Y Liang","year":"2021","unstructured":"Liang Y, Jeganathan S, Marastoni S, Sharp A, Figueiredo I, Marcellus R, et al. Emergence of enzalutamide resistance in prostate cancer is associated with BCL-2 and IKKB dependencies. Clin Cancer Res. 2021;27:2340\u201351.","journal-title":"Clin Cancer Res"},{"key":"1778_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.toxlet.2011.08.002","volume":"206","author":"CH Lin","year":"2011","unstructured":"Lin CH, Chen TJ, Chen SS, Hsiao PC, Yang RC. Activation of Trim17 by PPAR\u03b3 is involved in di(2-ethylhexyl) phthalate (DEHP)-induced apoptosis on Neuro-2a cells. Toxicol Lett. 2011;206:245\u201351.","journal-title":"Toxicol Lett"},{"key":"1778_CR27","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/pros.23843","volume":"79","author":"AB Pilling","year":"2019","unstructured":"Pilling AB, Hwang C. Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide. Prostate. 2019;79:1347\u201359.","journal-title":"Prostate"},{"key":"1778_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7472","volume":"13","author":"J Cao","year":"2024","unstructured":"Cao J, Yang M, Guo D, Tao Z, Hu X. Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer. Cancer Med. 2024;13:e7472.","journal-title":"Cancer Med"},{"key":"1778_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03173-w","volume":"21","author":"A Pearson","year":"2024","unstructured":"Pearson A, Koprivica M, Eisenbaum M, Ortiz C, Browning M, Vincennie T, et al. PPAR\u03b3 activation ameliorates cognitive impairment and chronic microglial activation in the aftermath of r-mTBI. J Neuroinflammation. 2024;21:194.","journal-title":"J Neuroinflammation"},{"key":"1778_CR30","doi-asserted-by":"crossref","unstructured":"Beshiri M, Agarwal S, Yin JJ, Kelly K. Prostate organoids: emerging experimental tools for translational research. J Clin Investig. 2023; 133:e169616.","DOI":"10.1172\/JCI169616"},{"key":"1778_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23:87\u201398.","journal-title":"Nat Cell Biol"},{"key":"1778_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C. Single-cell mRNA quantification and differential analysis with Census. Nat Methods. 2017;14:309\u201315.","journal-title":"Nat Methods"},{"key":"1778_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.eururo.2017.04.005","volume":"72","author":"R Wang","year":"2017","unstructured":"Wang R, Sun Y, Li L, Niu Y, Lin W, Lin C, et al. Preclinical study using Malat1 small interfering RNA and androgen receptor splicing variant 7 degradation enhancer ASC-J9(\u00ae) to suppress enzalutamide-resistant prostate cancer progression. Eur Urol. 2017;72:835\u201344.","journal-title":"Eur Urol"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01778-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:16:15Z","timestamp":1781324175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01778-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":33,"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01778-7","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of FUSCC (No. 050432-4-2307E) in accordance with the Declaration of Helsinki, and written informed consent was obtained from each patient. For the mouse experiments, all animals were housed under a specific pathogen-free environment, and all in vivo experiments were reviewed and approved by the Institutional Animal Care and Use Committee of the FUSCC (FUSCC-IACUC-S2023-0485).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}